Hao-En Jan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hao-En Jan has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Wen-Chien Ko
Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Center for Infection Control, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
6 shared publications - Nan-Yao Lee
Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Center for Infection Control, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
4 shared publications - Ching-Lung Lo
Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Center for Infection Control, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
3 shared publications - Cong-Tat Cia
Department of Internal Medicine, College of Medicine, National Cheng Kung University, National Cheng Kung University Hospital
2 shared publications - Tian-Yu You
Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
2 shared publications - Wen-Liang Lin
Department of Pharmacy, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
2 shared publications
Latest Publications
- Open Access
- 19 February 2026
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 59 (4) , 527-528
Etiological identification of Orientia tsutsugamushi by metagenomic next-generation sequencing in an adult with septic shock in Taiwan
- 19 February 2026
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 59 (4) , 527-528
Open AccessEtiological identification of Orientia tsutsugamushi by metagenomic next-generation sequencing in an adult with septic shock in Taiwan
- Open Access
- 11 August 2025
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 59 (1) , 85-90
Application of antimicrobial stewardship interventions improves outcomes in adults with bloodstream infection caused by multidrug-resistant Enterobacteriaceae
- 11 August 2025
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 59 (1) , 85-90
Open AccessApplication of antimicrobial stewardship interventions improves outcomes in adults with bloodstream infection caused by multidrug-resistant Enterobacteriaceae
- Open Access
- 17 March 2025
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 58 (4) , 490-492
Oseltamivir-resistant influenza in a fatal immunocompromised adult
- 17 March 2025
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 58 (4) , 490-492
Open AccessOseltamivir-resistant influenza in a fatal immunocompromised adult
- Open Access
- 29 July 2024
- Published by MDPI AG in Journal of Fungi
- Vol. 10 (8) , 530
PCR-Based Microarray Enhances Diagnosis of Culture-Negative Biopsied Tissue in Patients with Invasive Mold Infections: Real-World Experience in a Tertiary Medical Center
A fungal polymerase chain reaction (PCR) amplifies conserved genes across diverse species, combined with the subsequent hybridization of amplicons using a specific oligonucleotide microarray, allowing for the rapid detection of pathogens at the species level. However, the performance of microarrays in diagnosing invasive mold infections (IMI) from infected tissue samples is rarely reported. During the 4-year study period, all biopsied tissue samples from patients with a suspected IMI sent for microarray assays were analyzed. A partial segment of the internal transcribed spacer (ITS) region was amplified by nested PCR after DNA extraction. Amplicons were hybridized with specific probes for a variety of mold species using an in-house oligonucleotide microarray. A total of 80 clinical samples from 74 patients were tested. A diagnosis of an IMI was made in 10 patients (4 proven, 1 probable, 3 possible, 2 clinical suspicion). The PCR/microarray test was positive for three out of four proven IMIs, one probable IMI, and one out of three possible IMIs. Two patients with positive PCR/microarray findings were considered to have clinical suspicion of an IMI, and their responsible physicians initiated antifungal therapy despite the absence of supporting microbiological and histological evidence. Clinical diagnoses were categorized into non-IMI and IMI groups (including proven, probable, possible, and clinical suspicion). The sensitivity and specificity of the microarray in diagnosing the IMIs were 70% and 95.7%, respectively, while the sensitivity and specificity of the culture and histological findings were 10%/96.3% and 40.0%/100%, respectively. PCR-based methods provide supportive microbiological evidence when culture results are inconclusive. The combination of a microarray with fungal culture and histology promotes the precise diagnosis of IMIs in difficult-to-diagnose patients.
- 29 July 2024
- Published by MDPI AG in Journal of Fungi
- Vol. 10 (8) , 530
Open AccessPCR-Based Microarray Enhances Diagnosis of Culture-Negative Biopsied Tissue in Patients with Invasive Mold Infections: Real-World Experience in a Tertiary Medical Center
A fungal polymerase chain reaction (PCR) amplifies conserved genes across diverse species, combined with the subsequent hybridization of amplicons using a specific oligonucleotide microarray, allowing for the rapid detection of pathogens at the species level. However, the performance of microarrays in diagnosing invasive mold infections (IMI) from infected tissue samples is rarely reported. During the 4-year study period, all biopsied tissue samples from patients with a suspected IMI sent for microarray assays were analyzed. A partial segment of the internal transcribed spacer (ITS) region was amplified by nested PCR after DNA extraction. Amplicons were hybridized with specific probes for a variety of mold species using an in-house oligonucleotide microarray. A total of 80 clinical samples from 74 patients were tested. A diagnosis of an IMI was made in 10 patients (4 proven, 1 probable, 3 possible, 2 clinical suspicion). The PCR/microarray test was positive for three out of four proven IMIs, one probable IMI, and one out of three possible IMIs. Two patients with positive PCR/microarray findings were considered to have clinical suspicion of an IMI, and their responsible physicians initiated antifungal therapy despite the absence of supporting microbiological and histological evidence. Clinical diagnoses were categorized into non-IMI and IMI groups (including proven, probable, possible, and clinical suspicion). The sensitivity and specificity of the microarray in diagnosing the IMIs were 70% and 95.7%, respectively, while the sensitivity and specificity of the culture and histological findings were 10%/96.3% and 40.0%/100%, respectively. PCR-based methods provide supportive microbiological evidence when culture results are inconclusive. The combination of a microarray with fungal culture and histology promotes the precise diagnosis of IMIs in difficult-to-diagnose patients.
- Open Access
- 30 May 2024
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 57 (4) , 594-600
Efficacy of short- versus prolonged-courses of antimicrobial therapy for carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A propensity score-matched cohort study
- 30 May 2024
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 57 (4) , 594-600
Open AccessEfficacy of short- versus prolonged-courses of antimicrobial therapy for carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A propensity score-matched cohort study
- Open Access
- 7 September 2023
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 56 (6) , 1253-1260
Clinical impact of the combination of rapid species identification and antifungal stewardship intervention in adults with candidemia
- 7 September 2023
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 56 (6) , 1253-1260
Open AccessClinical impact of the combination of rapid species identification and antifungal stewardship intervention in adults with candidemia